跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,705 条关于
“Samsung SDS”
全部
2,705
临床试验
1,894
药物
321
机构
153
资讯
337
12天前
Hanmi Pharmaceutical to Fully Deploy AI Across Quality Assurance, Training on 4,000 SOPs
去年
Samsung Bioepis to Become Wholly-Owned Subsidiary of Samsung Biologics in Strategic Restructuring
去年
Samsung Biologics Expands Into Preclinical Research with Launch of Samsung Organoids Drug Screening Platform
9个月前
Samsung Biologics Reaches 400 Global Manufacturing Approvals, Reinforcing CDMO Leadership
去年
Samsung Bioepis' Opuviz (Eylea Biosimilar) Receives European Commission Approval
去年
European Commission Approves Samsung Bioepis' Aflibercept Biosimilar, OPUVIZ
去年
European Commission Approves Samsung Bioepis' Aflibercept Biosimilar, OPUVIZ
9个月前
Samsung Biologics Completes Strategic Spinoff to Enhance Biosimilar and Novel Drug Development
去年
Samsung Bioepis' Opuviz (Aflibercept) Biosimilar Receives European Approval for Ophthalmic Use
9个月前
Samsung Biologics Acquires First U.S. Manufacturing Facility for $280M in Maryland
第 1 页,共 34 页
上一页
下一页